HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

XUANZHUBIO-B

64.100

+0.5000.79%

Volume:346.43K

Turnover:21.92M

Market Cap:33.20B

PE:- -

High:64.500

Open:63.400

Low:62.600

Close:63.600

52wk High:72.000

52wk Low:23.820

Shares:517.95M

HK Float Shares:160.70M

Volume Ratio:0.77

T/O Rate:0.22%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:35.84

PE(LYR):- -

PS:948.62

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Xuanzhu Biopharmaceutical (02575) Publishes Monthly Return for October 2025

Bulletin Express

HK Stock Movement | XUANZHUBIO-B (02575) Surges Over 9% at Close to Hit Record High After NG-350A Granted FDA Fast Track Designation

BRIEF-Xuanzhu Biopharmaceutical Says NG-350A Granted Fast Track Designation By U.S. FDA

Xuanzhu Biopharmaceutical (2575) Announces U.S. FDA Fast Track Designation for NG-350A

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02575"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02575","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02575\",,,,,undefined,":{"symbol":"02575","market":"HK","secType":"STK","nameCN":"XUANZHUBIO-B","latestPrice":64.1,"timestamp":1763021314350,"preClose":63.6,"halted":0,"volume":346426,"delay":0,"floatShares":160701996,"shares":517947790,"eps":0,"marketStatus":"Not Yet Opened","change":0.5,"latestTime":"11-13 16:08:34","open":63.4,"high":64.5,"low":62.6,"amount":21917564,"amplitude":0.029874,"askPrice":64.1,"askSize":2500,"bidPrice":63.4,"bidSize":3500,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1763083800000},"marketStatusCode":0,"adr":0,"listingDate":1760457600000,"exchange":"SEHK","adjPreClose":63.6,"openAndCloseTimeList":[[1762997400000,1763006400000],[1763010000000,1763020800000]],"volumeRatio":0.7680982879508569,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02575\",,,,,undefined,":{"symbol":"02575","floatShares":160701996,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7680982879508569,"shares":517947790,"dividePrice":0,"high":64.5,"amplitude":0.029874,"preClose":63.6,"low":62.6,"week52Low":23.82,"pbRate":"35.84","psRate":"948.62","week52High":72,"institutionHeld":0,"latestPrice":64.1,"committee":0.166667,"eps":0,"divideRate":0,"volume":346426,"delay":0,"ttmEps":0,"open":63.4,"prevYearClose":11.6,"prevWeekClose":64.95,"prevMonthClose":63.6,"prevQuarterClose":11.6,"fiveDayClose":69.65,"twentyDayClose":26.3,"sixtyDayClose":11.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02575\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02575\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02575\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02575\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02575","date":"2025-11-12","current":-54.21583,"percent":0.421053,"low":-59.374256,"twenty":-55.744273,"median":-53.927391,"eighty":-36.85516,"high":-22.444691,"avg":-48.090577,"sd":11.651789,"marketCap":32941479444},"quantilePoints":[{"date":"2025-10-17","current":-28.93414,"twenty":-27.261252,"median":-24.751919,"eighty":-23.367582,"marketCap":17558430081},{"date":"2025-10-24","current":-50.850969,"twenty":-50.816841,"median":-33.923646,"eighty":-26.424807,"marketCap":30869688284},{"date":"2025-10-31","current":-54.182971,"twenty":-53.663557,"median":-50.808309,"eighty":-28.95487,"marketCap":32941479444},{"date":"2025-11-07","current":-55.367666,"twenty":-55.639174,"median":-53.630543,"eighty":-30.992132,"marketCap":33640708960},{"date":"2025-11-12","current":-54.21583,"twenty":-55.744273,"median":-53.927391,"eighty":-36.85516,"marketCap":32941479444}],"updateTime":1763071726509},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02575\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1126191866","title":"Xuanzhu Biopharmaceutical (02575) Publishes Monthly Return for October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1126191866","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126191866?lang=en_us&edition=fundamental","pubTime":"2025-11-06 16:43","pubTimestamp":1762418594,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical Co., Ltd. (02575) announced its monthly return for the period ended 31 October 2025. According to the filing, the company’s total issued H shares remained at 160,701,996,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"gpt_icon":0},{"id":"1132711582","title":"HK Stock Movement | XUANZHUBIO-B (02575) Surges Over 9% at Close to Hit Record High After NG-350A Granted FDA Fast Track Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=1132711582","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132711582?lang=en_us&edition=fundamental","pubTime":"2025-11-06 15:54","pubTimestamp":1762415678,"startTime":"0","endTime":"0","summary":"XUANZHUBIO-B (02575) surged over 9% in late trading, reaching a record high of HK$71.6. By the time of writing, the stock was up 6.41% at HK$69.7, with a turnover of HK$38.59 million. The rally...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4017","NG","02575"],"gpt_icon":0},{"id":"2578339937","title":"BRIEF-Xuanzhu Biopharmaceutical Says NG-350A Granted Fast Track Designation By U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2578339937","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578339937?lang=en_us&edition=fundamental","pubTime":"2025-10-28 18:37","pubTimestamp":1761647874,"startTime":"0","endTime":"0","summary":"BRIEF-Xuanzhu Biopharmaceutical Says NG-350A Granted Fast Track Designation By U.S. FDAOct 28 (Reuters) - Xuanzhu Biopharmaceutical Co Ltd 2575.HK:NG-350A GRANTED FAST TRACK DESIGNATION BY U.S. FDAFurther company coverage: 2575.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nFWN3W90C9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"gpt_icon":0},{"id":"1189413377","title":"Xuanzhu Biopharmaceutical (2575) Announces U.S. FDA Fast Track Designation for NG-350A","url":"https://stock-news.laohu8.com/highlight/detail?id=1189413377","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189413377?lang=en_us&edition=fundamental","pubTime":"2025-10-28 17:15","pubTimestamp":1761642933,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical Co., Ltd. (2575), a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd., announced that NG-350A—licensed from clinical-stage oncology company Akamis Bio Ltd.—has been...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02575\",params:#limit:6,delay:false,,,undefined,":[]}}